標(biāo)題: Titlebook: Global Perspectives in Ocular Oncology; Bhavna V. Chawla,Mary E. Aronow Book 2022 The Editor(s) (if applicable) and The Author(s), under e [打印本頁] 作者: 爆裂 時間: 2025-3-21 19:39
書目名稱Global Perspectives in Ocular Oncology影響因子(影響力)
書目名稱Global Perspectives in Ocular Oncology影響因子(影響力)學(xué)科排名
書目名稱Global Perspectives in Ocular Oncology網(wǎng)絡(luò)公開度
書目名稱Global Perspectives in Ocular Oncology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Global Perspectives in Ocular Oncology被引頻次
書目名稱Global Perspectives in Ocular Oncology被引頻次學(xué)科排名
書目名稱Global Perspectives in Ocular Oncology年度引用
書目名稱Global Perspectives in Ocular Oncology年度引用學(xué)科排名
書目名稱Global Perspectives in Ocular Oncology讀者反饋
書目名稱Global Perspectives in Ocular Oncology讀者反饋學(xué)科排名
作者: 自負(fù)的人 時間: 2025-3-21 23:45
Intravenous Chemotherapy for Retinoblastoma: A Pediatric Oncologist’s Perspective at treatment outset. Lastly, CEV does not cause infertility. Febrile neutropenia is expected in approximately 10% of patients with allergic reactions in 5%..This chapter describes when and how to administer appropriate systemic chemotherapy critical to saving the life and preserving as much vision 作者: 帶子 時間: 2025-3-22 03:03 作者: rheumatology 時間: 2025-3-22 07:24
Intra-vitreal Chemotherapy for Vitreoretinal Lymphomaing results and almost no adverse effects. Limited experience with intra-vitreal injections of other drugs also was found to be effective for the cure of VRL. Other drugs have been experimentally tested in animal models and may be used in the future.作者: 吵鬧 時間: 2025-3-22 09:24
A Macroeconomic Monetary Circuit,-ophthalmic outcomes such as disease progression and death. Potential strategies to overcome this barrier may include developing minimum data sets for ocular cancers and incorporating standardized discrete data elements into electronic health records. While there are existing hurdles for implementat作者: 滋養(yǎng) 時間: 2025-3-22 16:56
https://doi.org/10.1007/978-1-4842-9568-7 at treatment outset. Lastly, CEV does not cause infertility. Febrile neutropenia is expected in approximately 10% of patients with allergic reactions in 5%..This chapter describes when and how to administer appropriate systemic chemotherapy critical to saving the life and preserving as much vision 作者: 滋養(yǎng) 時間: 2025-3-22 18:49
Managing the Size of a Problem,amatically, although the prognosis of metastatic disease in developing countries is still dismal. A proportion of distant metastatic disease can be cured with intensive multimodal chemotherapy and autologous stem cell rescue; however, patients with CNS disease require development of novel management作者: Cuisine 時間: 2025-3-22 23:51
Introduction to Operating Systems,ing results and almost no adverse effects. Limited experience with intra-vitreal injections of other drugs also was found to be effective for the cure of VRL. Other drugs have been experimentally tested in animal models and may be used in the future.作者: amphibian 時間: 2025-3-23 01:24 作者: 積習(xí)已深 時間: 2025-3-23 07:31 作者: 省略 時間: 2025-3-23 12:29 作者: 狗窩 時間: 2025-3-23 16:06
Intra-arterial Chemotherapy for Retinoblastoma: A Team Effortatment for moderate and advanced RB (stage B to selected E), especially in eyes that would otherwise undergo enucleation. Intra-arterial chemosurgery conserves many eyes with retinoblastoma avoiding at the same time the risks of systemic chemotherapy and radiotherapy.作者: BRAWL 時間: 2025-3-23 19:54
Systemic and Genetic Associations of Ocular and Ocular Adnexal Neoplasmsquate knowledge and approach to genetic/systemic evaluation and counseling patient and family. This chapter addresses some of the common and infrequently associated systemic associations, highlights currently known genetic mutations, underscoring the value of complete systemic evaluation, regular screening, genetic testing, and counseling.作者: floodgate 時間: 2025-3-24 01:02 作者: EXULT 時間: 2025-3-24 04:41
ontributors.Broken up into seven sections and includes a sec.Eye cancers vary in presentation depending upon geographic location and access to healthcare.?.Global Perspectives in Ocular Oncology.?offers an international platform for leading ocular oncologists and multidisciplinary specialists to hig作者: 無辜 時間: 2025-3-24 06:53 作者: 外觀 時間: 2025-3-24 14:30
https://doi.org/10.1007/978-0-8176-4591-5quate knowledge and approach to genetic/systemic evaluation and counseling patient and family. This chapter addresses some of the common and infrequently associated systemic associations, highlights currently known genetic mutations, underscoring the value of complete systemic evaluation, regular screening, genetic testing, and counseling.作者: cathartic 時間: 2025-3-24 16:18 作者: 壯觀的游行 時間: 2025-3-24 20:53 作者: Grasping 時間: 2025-3-25 02:11 作者: Immunization 時間: 2025-3-25 04:54 作者: 做方舟 時間: 2025-3-25 09:27 作者: 漂白 時間: 2025-3-25 13:03 作者: Obloquy 時間: 2025-3-25 19:43 作者: dendrites 時間: 2025-3-25 20:20 作者: 連鎖 時間: 2025-3-26 01:45 作者: 公共汽車 時間: 2025-3-26 07:38
https://doi.org/10.1007/978-3-319-27853-7es is reported to be significantly lower in LMICs, probably because many do not reach a childbearing age. Given that retinoblastoma is a curable disease, these data are concerning and warrant intervention at national and international levels.作者: 黃瓜 時間: 2025-3-26 11:07
https://doi.org/10.1007/978-3-031-31816-0t strategies under investigation to avoid toxicity and improve survival. Finally, we look to the future and discuss emerging therapies, including upstream and downstream targets of the Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, immunomodulatory drugs, and immune checkpoint blockade.作者: IRK 時間: 2025-3-26 14:00 作者: FRONT 時間: 2025-3-26 17:12 作者: Deduct 時間: 2025-3-26 21:48 作者: AER 時間: 2025-3-27 04:26 作者: 就職 時間: 2025-3-27 06:02 作者: delegate 時間: 2025-3-27 11:12
Treatment Algorithms for Intraocular Retinoblastoma: An Ocular Oncologist’s Perspectiveimportant clinical information on these new modalities that has not been previously published in the literature, allowing the ocular oncologist to navigate the path between tumor relapse and potential treatment toxicities.作者: irreducible 時間: 2025-3-27 14:55
978-3-031-08252-8The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: 掃興 時間: 2025-3-27 19:14
https://doi.org/10.1007/978-3-031-08250-4ocular oncology; global care; eye cancer; retinoblastoma; pediatric oncology; uveal melanoma; radiation; en作者: visceral-fat 時間: 2025-3-28 01:49
Bhavna V. Chawla,Mary E. AronowOffers an international perspective on the varied spectrum of adult and pediatric eye cancers.Includes international and multidisciplinary contributors.Broken up into seven sections and includes a sec作者: 紡織品 時間: 2025-3-28 03:02 作者: Harass 時間: 2025-3-28 08:33 作者: Retrieval 時間: 2025-3-28 12:01
https://doi.org/10.1007/978-3-319-22309-4 when treating rare, orphan disease. With a variety of goals spanning from education to mentorship to patient advocacy, these societies inspire research, collaboration, and change. In this chapter, we highlight four different interest groups: two focused on young ocular oncologists (and pathologists作者: 彎曲的人 時間: 2025-3-28 16:26 作者: 膝蓋 時間: 2025-3-28 18:44
https://doi.org/10.1007/978-3-319-27853-7ncome countries (LMICs). Early detection and urgent referral to a specialized retinoblastoma treatment center is of utmost importance in order to save life, salvage the eye, and, in selected cases, retain vision. Advances in retinoblastoma screening, detection, and management in high-income countrie作者: ANTH 時間: 2025-3-29 01:23 作者: 永久 時間: 2025-3-29 03:46 作者: 嬉耍 時間: 2025-3-29 09:17
https://doi.org/10.1007/978-1-4842-9568-7boplatin, etoposide, and vincristine (CEV). This regimen is efficacious when used as chemoreduction (a neoadjuvant strategy to shrink intraocular tumors) as well as in the adjuvant setting post-enucleation and to treat orbital disease when combined with surgery and radiation therapy..Concerns raised作者: Immunization 時間: 2025-3-29 12:42 作者: NATAL 時間: 2025-3-29 18:31 作者: conspicuous 時間: 2025-3-29 20:00
https://doi.org/10.1007/978-3-031-31816-0c accuracy. The risk for relapse is high and relapse into the CNS can be fatal. The optimal treatment for PVRL is yet to be established. Therapeutic options are limited by drug penetration through the blood–retinal and blood–brain barriers, but different routes of delivery attempt to circumvent thes作者: anagen 時間: 2025-3-30 00:25 作者: EXUDE 時間: 2025-3-30 04:42
https://doi.org/10.1007/978-0-8176-4591-5ce. The general ophthalmologist is often faced with challenges of not only diagnosing them accurately and managing them optimally, but also with inadequate knowledge and approach to genetic/systemic evaluation and counseling patient and family. This chapter addresses some of the common and infrequen作者: Critical 時間: 2025-3-30 09:38 作者: acheon 時間: 2025-3-30 12:41 作者: CANON 時間: 2025-3-30 18:42
Managing the Size of a Problem,worse prognosis as compared to intraocular RB. The two most commonly used staging systems to denote these entities are the International Retinoblastoma Staging System and the American Joint Commission on Cancers’ TNMH staging. The imaging modality of choice is a Contrast Enhanced Magnetic Resonance 作者: Forehead-Lift 時間: 2025-3-30 21:47
Introduction to Programming Languages,atients developing metastatic disease eventually. Several clinical, histopathological, and genetic risk factors have been described for metastasis development. Improved localized control of the primary disease unfortunately could not be translated into improved survival results in the treatment of m作者: 沉著 時間: 2025-3-31 01:40
Introduction to Operating Systems, nervous system lymphoma (CNSL). The hallmark of VRL is the presence of lymphoma cells in the vitreous and retinal and sub-retinal infiltrates. Systemic chemotherapy and radiation therapy have been used for years to treat VRL. In the recent two decades, intra-vitreal chemotherapy as monotherapy or c作者: ODIUM 時間: 2025-3-31 08:33 作者: Ferritin 時間: 2025-3-31 10:43 作者: amorphous 時間: 2025-3-31 13:32
Worldwide Analysis: The Global Presentation of Retinoblastomancome countries (LMICs). Early detection and urgent referral to a specialized retinoblastoma treatment center is of utmost importance in order to save life, salvage the eye, and, in selected cases, retain vision. Advances in retinoblastoma screening, detection, and management in high-income countrie作者: 滑稽 時間: 2025-3-31 18:07 作者: 自戀 時間: 2025-3-31 22:15
